Sharon Townson
Technik-/Wissenschafts-/F&E-Leiter bei MONTE ROSA THERAPEUTICS, INC.
Aktive Positionen von Sharon Townson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 | - |
| Corporate Officer/Principal | 01.07.2020 | 01.12.2020 |
Karriereverlauf von Sharon Townson
Ehemalige bekannte Positionen von Sharon Townson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KYMERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2019 | 01.06.2020 |
| Corporate Officer/Principal | 01.04.2019 | 01.06.2020 | |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.06.2013 | 01.12.2018 |
Ausbildung von Sharon Townson
| University of Manchester Institute of Science & Technology | Doctorate Degree |
| University of Salford | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| KYMERA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |
- Börse
- Insiders
- Sharon Townson
- Erfahrung
